North Carolina – Regional Life Sciences Roundup – November 6, 2026
North Carolina’s life sciences news this week puts the capacity to do the work alongside the science itself. Progress depends on more than the next development milestone. It also takes funding to sustain the work and experienced people to keep facilities running. That connection runs through this week’s news: the resources behind development deserve attention alongside the clinical updates.
Durham’s Precision BioSciences priced an offering expected to generate approximately $125 million in gross proceeds, before underwriting discounts, commissions, and expenses. Opus enrolled 11 participants in the cohort against an original target of five and expects topline three-month data in the first quarter of 2027. Its gene therapy is being studied for BEST1-related retinal diseases. Elsewhere in Durham, the Glioblastoma Foundation’s laboratory began accepting patient tumor samples for whole-genome DNA methylation profiling, adding a laboratory operations story to the week’s financing and trial updates.
The people behind those operations come into focus at Biogen. Lynsey Copley was named associate director of facilities engineering at its Research Triangle Park site after more than nine years with the company. Her experience includes coordinating facility and utility upgrades totaling more than $100 million, bringing the facilities work behind manufacturing into the same frame as clinical development.
For readers considering where their skills fit into this work, our guide to biopharma manufacturing careers explores the competencies and career paths behind production, including organizations building talent pipelines in North Carolina.
Financial
Tracking the capital moving through North Carolina: funding rounds, M&A activity, and investment trends shaping NC’s life sciences companies.
Ingersoll Rand acquires IVEK Corporation in life sciences expansion move
Ingersoll Rand acquired IVEK Corporation to expand its life sciences solutions business. IVEK specializes in precision fluid dispensing systems used in laboratory and manufacturing applications. The acquisition strengthens Ingersoll Rand’s position in the life sciences sector. Read More >
Precision BioSciences sets terms for $125 million equity raise through stock sale
Precision BioSciences priced an underwritten offering of common stock and pre-funded warrants expected to generate approximately $125 million in gross proceeds before expenses. The Durham, North Carolina, gene editing company priced its common shares at 75 each. Read More >
ViiV Healthcare commits $100 million to strengthen local HIV care across the U.S.
ViiV Healthcare committed $100 million to strengthen local HIV care networks across the United States. The commitment focuses on building more resilient networks at the local level to support care for people affected by HIV. Read More >
People
Who we’re buzzing about this week: the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Biogen promotes nine-year veteran to lead engineering at RTP manufacturing site
Biogen named Lynsey Copley associate director of facilities engineering at its Research Triangle Park, North Carolina, manufacturing site, effective October 2026. Copley brings more than nine years at the company, most recently serving as senior manager of facilities engineering. Read More >
Incyclix forms advisory panel ahead of planned 2027 pivotal trial for INX-315
Incyclix Bio formed a breast cancer steering committee to guide clinical development of investigational INX-315. The Research Triangle Park, North Carolina, company is preparing for a potential pivotal trial in 2027, with the committee advising on trial design and development. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across North Carolina’s life sciences and biotech employers.
What does North Carolina want employers to do this week for veterans?
North Carolina Governor Josh Stein proclaimed November 9 through 13 Employ a Veteran Week. Events across the state will help connect veterans with jobs, bringing employers and veteran job seekers together through the week’s workforce activities. Read More >
Science 37 wins 2026 award for a model that moves research out of clinics
Science 37, based in Morrisville, North Carolina, received the 2026 BioTechnology Innovation of the Year award for its direct-to-patient clinical trial delivery model. The model brings research visits into patients’ homes, with research-trained nurses conducting study visits. Read More >
Your Guide to a Career in Biopharma Manufacturing
Our guide to biopharma manufacturing careers explores the work behind producing vaccines, biologics, and cell therapies consistently and safely at scale. It covers skills, career pathways, and organizations building talent pipelines across BioBuzz’s regions, including North Carolina. Read More >
Who’s Hiring
TOP EMPLOYER
FUJIFILM Biotechnologies
32 open roles
FUNCTIONAL AREAS
- Engineering, Automation & CQV
- Facilities, Construction & Environmental Health & Safety
- Manufacturing & Technical Operations
Open now: Warehouse Associate 3 – Holly Springs, NC
Amgen
57 open roles
FUNCTIONAL AREAS
- Manufacturing & Technical Operations
- Engineering, Automation & CQV
- Facilities, Construction & Environmental Health & Safety
Open now: Clean Utilities Sr Engineer – Holly Springs, NC
AbbVie
31 open roles
FUNCTIONAL AREAS
- Engineering, Automation & CQV
- Project & Program Management
- Facilities, Construction & Environmental Health & Safety
Open now: Senior Manager, Infrastructure Project – Durham, NC
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across North Carolina.
Glioblastoma Foundation opens testing facility with single-assay methylation profiling
The Glioblastoma Foundation’s Gliolab in Durham, North Carolina, is accepting patient tumor samples for whole-genome DNA methylation profiling. The laboratory uses the Epignostix Classifier to characterize tumors, combining molecular profiling and glioblastoma subtype characterization in a single assay. Read More >
Opus Genetics wraps dosing in rare retinal disease gene therapy cohort, awaits Q1 results
Opus Genetics completed dosing in the 11-participant second cohort of its Phase 1/2 trial of investigational OPGx-BEST1 for BEST1-related retinal diseases. The Research Triangle Park, North Carolina, company expects topline three-month data in the first quarter of 2027. Read More >
Ecosystem
The partnerships, programs, and policy moves building North Carolina’s life sciences infrastructure, and the organizations driving it forward.
Premier Launches Industry-Leading Healthcare Data and Intelligence Foundation to Transform Health System Performance
Premier launched a healthcare data and intelligence foundation aimed at supporting health system performance. The launch brings data and intelligence together in an initiative focused on how health systems assess and improve their performance. Read More >
Network Bio Announces Research Collaboration with a Leading Academic Medical Center to Build AI Models of Human Disease from Biospecimens
Network Bio announced a research collaboration with an academic medical center to build artificial intelligence models of human disease. The collaborators will use biospecimens as the basis for developing those disease models. Read More >
Other [Good] Reads
Editor’s picks from across the web: the stories, videos, and podcasts shaping the conversation in NC biotech and life sciences this week.
What stopped clinical AI tools from leaving the pilot phase at Velocity?
Velocity Clinical Research shared its experience putting artificial intelligence into production at the 2026 Veeva Research and Development Summit. Its reflections focus on the challenge of moving clinical research tools beyond demonstrations and into sustained operational use. Read More >
Premier Research analyzes new FDA position on timing for Alzheimer’s trials
Premier Research examines Food and Drug Administration guidance on early Alzheimer’s drug development and its implications for clinical trial design. The discussion focuses on the guidance’s emphasis on early intervention, with an update published October 16, 2026. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across North Carolina’s life sciences ecosystem that you don’t want to miss.
STEM Career Day
Friday, November 13 · 8:00 AM–3:30 PM · Boone, NC
Hosted by Appalachian State University | Register Now >
LEAD 2026: Integrating Higher Ed into the Corporate R&D Value Chain
Thursday, November 12 · 9:00 AM–4:30 PM · Durham, NC
Hosted by HBCUGrow | Register Now >
Triangle Biotech Tuesday November Event
Tuesday, November 10 · 5:30 PM–7:30 PM · Durham, NC
Hosted by Triangle Biotech | Register Now >
Did we miss something!? Drop us a line →
Stay connected to North Carolina’s life sciences.
